PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Batavia Bioservices and UvA Holding announce STEP(TM) technology exclusive license

Category : Stocks, World News

LEIDEN, THE NETHERLANDS–(Marketwired – Apr 29, 2013) – Batavia Bioservices BV and UvA
Holding BV announced today that they have
successfully concluded an agreement granting Batavia Bioservices the
exclusive
rights to STEPT technology developed by scientists at CellaGenics BV,
an UvA
Holding BV company.

Read more: Batavia Bioservices and UvA Holding announce STEP(TM) technology exclusive license

Post to Twitter

Pharming Updates on Ongoing Call of First Tranche of EUR10 Million Equity Working Capital Facility

Category : Stocks

LEIDEN, THE NETHERLANDS–(Marketwire – Aug 20, 2012) – Biotech company Pharming Group NV
(“Pharming” or “the Company”) (NYSE Euronext: PHARM) today announces that
the
investors have increased the first call under the facility by 16,440,148
shares
from 45,808,442 to 62,248,590.

Here is the original post: Pharming Updates on Ongoing Call of First Tranche of EUR10 Million Equity Working Capital Facility

Post to Twitter

Pharming provides management update

Category : Stocks

LEIDEN, THE NETHERLANDS–(Marketwire – Jun 19, 2012) – Biotech company Pharming Group NV
(“Pharming” or “the Company”) (NYSE Euronext: PHARM) today announces that
its
Chief Medical Officer Dr. Rienk Pijpstra has resigned from the Board of
Management, and will leave the company on September 1st.

Continue reading here: Pharming provides management update

Post to Twitter

Pharming announces presentation of new Ruconest(R) clinical data

Category : Stocks

LEIDEN, THE NETHERLANDS–(Marketwire – Jun 18, 2012) -

Continued here: Pharming announces presentation of new Ruconest(R) clinical data

Post to Twitter

Pharming reports financial results first quarter 2012

Category : Stocks

LEIDEN, NETHERLANDS–(Marketwire – Apr 26, 2012) – Biotech company Pharming Group NV
(“Pharming” or “the Company”) (NYSE Euronext: PHARM) today published its
financial report for the first quarter ended March 31, 2012.

Visit link: Pharming reports financial results first quarter 2012

Post to Twitter